Minghuan Mao
Overview
Explore the profile of Minghuan Mao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qu H, Mao M, Wang K, Mu Z, Hu B
Transl Res
. 2023 Nov;
266:32-48.
PMID: 37992987
The current study performed bioinformatics and in vitro and in vivo experiments to explore the effects of ADAM8 on the malignant behaviors and immunotherapeutic efficacy of renal clear cell carcinoma...
2.
Chen F, Yang L, Peng X, Mao M, Liu X, Song J, et al.
Mol Immunol
. 2022 Sep;
151:204-217.
PMID: 36179603
Atypical chemokine receptor 3 (ACKR3) has been linked to the tumor microenvironment. This work investigates the effects of ACKR3 and its regulatory molecules on the chemotactic migration of tumor-associated macrophages...
3.
Hu J, Yang L, Peng X, Mao M, Liu X, Song J, et al.
Hum Cell
. 2022 Sep;
35(6):1838-1855.
PMID: 36087219
Liver is a well-known immunological organ with unique microenvironment. In normal conditions, the rich immune-infiltrating cells cooperate with non-parenchymal cells, such as Kupffer cells (KCs). The presence of liver immunosuppressive...
4.
Hu J, Yang L, Peng X, Mao M, Liu X, Song J, et al.
Inflammation
. 2022 Jun;
45(6):2309-2324.
PMID: 35715591
Aldehyde dehydrogenase 2 (ALDH2) has been implicated in the progression of liver hepatocellular carcinoma (LIHC). The most important feature of LIHC is the immune escape process. This study sets to...
5.
Liu J, Zhu X, Yu L, Mao M
J Enzyme Inhib Med Chem
. 2022 Mar;
37(1):866-875.
PMID: 35350943
A series of sulphonamide hybrids were designed, synthesised, and identified as potential lysine-specific demethylase 1 (LSD1) inhibitors. Bladder cancer cell lines were cultured to evaluate the antiproliferative activity. Inhibitory evaluation...
6.
Mao M, Yang L, Hu J, Liu B, Zhang X, Liu Y, et al.
Exp Mol Med
. 2022 Jan;
54(1):47-60.
PMID: 35031788
The neuronally expressed developmentally downregulated 4 (NEDD4) gene encodes a ubiquitin ligase that targets the epithelial sodium channel for degradation and has been implicated in tumor growth in various cancers....
7.
Mao M, Yang L, Hu J, Liu B, Liu C, Zhang X, et al.
Genomics
. 2021 Apr;
113(4):2122-2133.
PMID: 33894310
This study aimed to investigate the function of OCT3/4 on tumor immune escape in bladder cancer. Initially, the expression of OCT3/4, TET1, NRF2 and MDM2 was quantified in tumor tissues...
8.
Yang H, Qu H, Huang H, Mu Z, Mao M, Xie Q, et al.
Cell Biol Int
. 2021 Mar;
45(7):1510-1522.
PMID: 33728699
Bladder cancer (BC), as one of the most common malignant cancers of the urinary system, has a high incidence and mortality rates. Recently, increasing studies have indicated that exosomes can...
9.
Xu H, Mao M, Zhao R, Zhao Q
Technol Cancer Res Treat
. 2021 Mar;
20:1533033821995284.
PMID: 33641532
Background: Prostate cancer is the most commonly diagnosed cancer and second leading cause of cancer death in men. Enoxacin, a third-generation fluoroquinolone antibiotic, was found with anti-proliferative effects against many...
10.
Liu J, Xue D, Zhu X, Yu L, Mao M, Liu Y
Invest New Drugs
. 2019 Jun;
38(2):525-532.
PMID: 31183632
Novel quinoline-dithiocarbamate hybrids were synthesized and designed by the molecular hybridization strategy. All these derivatives were evaluated for their antiproliferative activity against three selected cancer cell lines (MGC-803, HepG-2 and...